Target intelligence / Profile preview

Glutamate-gated chloride channel subunit alpha-3B (GluClα3B)

Target
GluClα3B
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor family, Glutamate-gated chloride channel
01

Overview

Dirofilaria immitis GluClα3B is a specific subunit of the glutamate-gated chloride channel (GluCl) found in the heartworm, a parasitic nematode. These channels are members of the Cys-loop family of ligand-gated ion channels and are unique to invertebrates, making them ideal targets for anthelmintic therapy. In the parasite, GluCls mediate inhibitory neurotransmission; when activated by the neurotransmitter glutamate, they allow chloride ions to flow into the cell, causing hyperpolarization and inhibiting electrical activity. This process is critical for the parasite's locomotion, feeding, and reproduction. This receptor is the primary molecular target for macrocyclic lactones, such as ivermectin and moxidectin, which are the gold standard for heartworm prevention. These drugs act as potent allosteric agonists, locking the channel in an open state, which leads to the flaccid paralysis and eventual death of the microfilariae and larvae. Understanding the structure and function of the alpha-3B subunit is particularly important for addressing the growing challenge of macrocyclic lactone resistance observed in certain heartworm strains, as mutations in these channel subunits can reduce drug binding affinity or channel sensitivity.

Other names
Dim-GLC-3BDirofilaria immitis GLC-3BGlutamate-gated chloride channel alpha 3B subunitGluCl alpha 3B
02

Mechanism of action

Positive allosteric modulation and activation of the channel, leading to an influx of chloride ions, membrane hyperpolarization, and flaccid paralysis of the parasite's somatic muscles or pharynx.

03

Biological functions

Inhibitory neurotransmissionMotor controlPharyngeal pumpingSensory processing
04

Disease associations

DirofilariasisInfection
05

Safety considerations

Emerging drug resistance in Dirofilaria immitis populationsHost toxicity in P-glycoprotein deficient dog breeds (MDR1 mutation)Potential for off-target effects in host GABA receptors at high concentrations
06

Interacting drugs

Ivermectin

4 more in the full profile.

07

Biomarkers

GLC-3 genetic polymorphismsMacrocyclic lactone resistance markers

Beyond the preview

Go deeper on Glutamate-gated chloride channel subunit alpha-3B (GluClα3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate-gated chloride channel subunit alpha-3B (GluClα3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call